R Squared’s Sanara MedTech SMTI Stock Holding History

R Squared’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-50	Closed	-$1.66K	–	1316
2024 Q4	$1.66K	Buy	+50	New	+$1.7K	﹤0.01%	1480

Other funds holding SMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

R Squared's SMTI Position: Q1 2025 in Review

R Squared sold out of Sanara MedTech (SMTI) in Q1 2025, closing a stake of 50 shares — an estimated $1.66K sold.

R Squared first reported a position in SMTI in Q4 2024 and held it in 1 quarter. The position peaked at $1.66K in Q4 2024. 49 funds tracked by Wall St. Rank hold SMTI as of Q1 2025.

R Squared reported no remaining Sanara MedTech position as of Q1 2025 after selling out during the quarter.
R Squared sold 50 Sanara MedTech shares in Q1 2025, an estimated $1.66K.
R Squared first reported a position in Sanara MedTech in Q4 2024 and held it in 1 quarter.
R Squared's Sanara MedTech position peaked at $1.66K in Q4 2024.
49 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.